MAPT and progressive supranuclear palsy: The LC–MS/MS analysis was performed on neuronal Tau from transgenic mice expressing the mutation TauA152T (a risk factor for progressive supranuclear palsy (26)) purified by immunoprecipitation using the TauA152T specific antibody 1C5.